六大社区尸检研究中老年神经病理的患病率、相关性与共现:12项指标的统一分析
该协调横断面分析整合美国与英国六个社区尸检队列,纳入4354例80岁及以上死者,统一评估12种痴呆相关神经病理。结果显示神经病理共现率高,2695例中2443例(91%)存在六种关键神经病理中一种以上,1106例(41%)存在三种及以上;血管性与阿尔茨海默病特征在相关分析中分别聚类。
要点
- 2695例中2443例(91%)存在六种关键神经病理中一种以上,1106例(41%)存在三种及以上。
- 阿尔茨海默病神经病理改变(Braak分期与CERAD评分)属高置信度统一类别,血管性神经病理属低或中等置信度类别。
- LATE-NC与阿尔茨海默病指标呈中等关联,如与Braak分期ρ=0·31(95%CI 0·20-0·42)。
核心结论
- 血管性神经病理测量较阿尔茨海默病神经病理改变变异性更高、一致性更差,提示可能有助于开发新的血管性神经病理测量框架。
- 结果凸显老年人痴呆 underlying 脑病理的复杂性与多病共存,提示预防与治疗应多层面。
研究设计与样本
- 协调横断面分析,整合美国与英国六个社区尸检队列数据。
- 纳入所有80岁及以上死者,评估12种已知与痴呆相关的神经病理。
- 将测量按统一置信度分为低、中、高三组,描述患病率、相关性与共现。
主要发现
- 队列共纳入4354例80岁及以上有尸检数据的死者,各队列平均死亡年龄范围88·0-91·6岁。
- 2695例中2443例(91%)存在六种关键神经病理中一种以上,1106例(41%)存在三种及以上。
- 共现与痴呆状态呈强关联但非确定性关联。
- 相关分析中血管性与阿尔茨海默病特征分别聚类,LATE-NC与阿尔茨海默病指标呈中等关联(如Braak分期ρ=0·31 [95%CI 0·20-0·42])。
关键数值与推荐
- 阿尔茨海默病神经病理改变指标(Braak分期与CERAD评分)属高置信度统一类别。
- 血管性神经病理中,小动脉硬化、动脉粥样硬化、脑淀粉样血管病与腔隙属低置信度类别,大梗死与微梗死属中等置信度类别。
临床怎么用
- 原文未报告临床实践推荐。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Population-based autopsy studies provide valuable insights into the causes of dementia but are limited by sample size and restriction to specific populations. Harmonisation across studies increases statistical power and allows meaningful comparisons between studies. We aimed to harmonise neuropathology measures across studies and assess the prevalence, correlation, and co-occurrence of neuropathologies in the ageing population. METHODS: We combined data from six community-based autopsy cohorts in the US and the UK in a coordinated cross-sectional analysis. Among all decedents aged 80 years or older, we assessed 12 neuropathologies known to be associated with dementia: arteriolosclerosis, atherosclerosis, macroinfarcts, microinfarcts, lacunes, cerebral amyloid angiopathy, Braak neurofibrillary tangle stage, Consortium to Establish a Registry for Alzheimer's disease (CERAD) diffuse plaque score, CERAD neuritic plaque score, hippocampal sclerosis, limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC), and Lewy body pathology. We divided measures into three groups describing level of confidence (low, moderate, and high) in harmonisation. We described the prevalence, correlations, and co-occurrence of neuropathologies. FINDINGS: The cohorts included 4354 decedents aged 80 years or older with autopsy data. All cohorts included more women than men, with the exception of one study that only included men, and all cohorts included decedents at older ages (range of mean age at death across cohorts 88·0-91·6 years). Measures of Alzheimer's disease neuropathological change, Braak stage and CERAD scores, were in the high confidence category, whereas measures of vascular neuropathologies were in the low (arterioloscerosis, atherosclerosis, cerebral amyloid angiopathy, and lacunes) or moderate (macroinfarcts and microinfarcts) categories. Neuropathology prevalence and co-occurrence was high (2443 [91%] of 2695 participants had more than one of six key neuropathologies and 1106 [41%] of 2695 had three or more). Co-occurrence was strongly but not deterministically associated with dementia status. Vascular and Alzheimer's disease features clustered separately in correlation analyses, and LATE-NC had moderate associations with Alzheimer's disease measures (eg, Braak stage ρ=0·31 [95% CI 0·20-0·42]). INTERPRETATION: Higher variability and more inconsistency in the measurement of vascular neuropathologies compared with the measurement of Alzheimer's disease neuropathological change suggests the development of new frameworks for the measurement of vascular neuropathologies might be helpful. Results highlight the complexity and multi-morbidity of the brain pathologies that underlie dementia in older adults and suggest that prevention efforts and treatments should be multifaceted. FUNDING: Gates Ventures.
引用
- Nichols E, Merrick R, Hay SI, et al. The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community-based autopsy studies of dementia. Lancet Healthy Longev. 2023. PMID: 36870337. doi:10.1016/S2666-7568(23)00019-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。